Acumen Pharma Inc Live Stock Price Today, Share Analysis and Chart

Name: Acumen Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: Acumen Pharmaceuticals Inc
Rating: 1.30025
Author: Trendlyne DVM scores

about

Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass...

2.25 0.08 (3.69%)

37.50% Fall from 52W High

305.9K

XNAS Volume

XNAS 17 Jul, 2026 5:30 PM (EDT)

Not Eligible

Expensive Valuation

10.5 / 100

Technically Neutral

41.5 / 100

No estimates available

Acumen Pharma Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Acumen Pharma Inc Live Stock Price Today, Share Analysis and Chart

Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass...

37.50% Fall from 52W High

SWOT Analysis

Acumen Pharma Inc Live Price Chart

Acumen Pharma Inc Live Price Chart